This study compound was first claimed by Hoffman-La Roche in 2009. It’s one among a number of benzodiazepines from the imidazobenzodiazepine subgroup imagined to deliver nootropic Rewards. It’s unclear why this drug wasn’t investigated further more, but there are stories this compound continues to be detected on designer and street-level https://pauli158zfj7.empirewiki.com/user